FRANKLIN LAKES, N.J., Aug. 4, 2025 /PRNewswire/ -- BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced plans to invest more than $35 million ...

Due to advances in technology and increased development of parenteral drugs, one of the fastest growing choices for drug delivery in the pharmaceutical industry is the prefilled syringe (PFS). Not ...

The move comes in response to increasing delivery demands for GLP-1s, plus broader conversations about pharmaceutical ...

BD, a leading global medical technology company, is investing more than $35 million to expand prefilled flush syringe manufacturing at its Columbus, Neb., facility. With the investment, the company ...

Sharps Technology Inc. (NASDAQ: STSS) is pushing into the copolymer prefillable syringe market thanks to a deal with Nephron Pharmaceuticals Corp., a leader in contract manufacturing of generic ...

The new 0.5mL single-dose, prefilled syringe has the same composition as the original 2-vial presentation but removes the need for reconstitution. The Food and Drug Administration (FDA) has approved a ...

The "Prefilled Syringe Fill Finish Manufacturing Market Industry Trends and Global Forecasts to 2035: Distribution by Type of Therapeutic Area, Type of Syringe Barrel Material, Number of Barrel ...

BD to Invest $35 Million in Nebraska Facility to Expand Prefilled Flush Syringe Manufacturing to Support U.S. Health Care Provided by PR Newswire Aug 4, 2025, 10:50:00 AM BD to Invest $35 Million in ...